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Background: The Mayo Clinic Risk Score (MCRS) comprises 7 pre-procedural clinical variables (age, creatinine, ejection fraction, myocardial 
infarction (MI) ≤24 hours, shock, peripheral arterial disease (PAD) and heart failure) which have been validated to predict cardiovascular 
complications after percutaneous coronary intervention (PCI) and coronary bypass surgery (CABG).
Methods: We assessed the ability of the MCRS to predict in-hospital mortality among 9,827 consecutive PCIs and 8,895 isolated CABGs between 
April 2004 and June 2008. Discrimination ability and calibration of MCRS was assessed using receiver operating characteristics (ROC) and Hosmer-
Lemeshow (HL) statistics, respectively. 
Results: The MCRS variables in the PCI and CABG cohorts are as follows:- 
Mean Age (yrs)
Renal 
Impairment
Mean EF (%) PAD Heart Failure MI ≤24 hours Shock
PCI 64.6±12.0 4.2% 54±12 7.0% 5.0% 23.3% 2.4%
CABG 65.8±10.3 5.0% 56±15 12.7% 6.0% 4.1% 1.7%
The observed and predicted in-hospital mortality rates in the PCI group were 1.55% vs. 1.12% (p<0.01) and 1.78% vs. 0.75% (p<0.01) in the CABG 
group., The discriminatory ability of MCRS to predict in-hospital mortality after PCI was high (area under ROC=0.94, 95%CI 0.92-0.96) but somewhat 
lower after CABG (area under ROC=0.80, 95%CI 0.77-0.84). Performance of MCRS was maintained among subgroups. HL goodness-of-fit between 
MCRS and in-hospital mortality in the PCI cohort was good (p=0.67) but poorer in the CABG cohort (p=0.03)
Conclusions: The MCRS predicts mortality after PCI in this Australian cohort. Model recalibration may improve its use in CABG patients.
